Price $7.30 |
Market Cap
175.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
6.48
|
P/S
3.6
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-1.1K
|
FCF
0.0
|
|
Op. Margin
0.70%
|
Net Margin
-6.90%
|
ROE
-16.10%
|
ROI
0.70%
|
|
ROA
-6.30%
|
EPS Growth
-821.00%
|
Current Ratio
3.7
|
Debt/Equity
45.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc (AMRX) | $5.90 | - | - | 2.02B | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $24.21 | - | - | 888.4M | Strong Buy |
| Regulus Therapeutics Inc (RGLS) | $1.29 | - | - | 113.1M | Strong Buy |
| Aravive Inc (ARAV) | $5.44 | - | - | 129.6M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $6.78 | - | - | 217.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
